 PARIS and CAMBRIDGE, Mass., Oct. 04, 2021 GLOBE NEWSWIRE -- Biophytis SA NasdaqCM: BPTS, Euronext Growth Paris: ALBPS, a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces the issuance of 240 Bonds Redeemable in Cash and New and Existing Shares ORNANE for a total amount of 6 million under its existing convertible bond agreement with Atlas, a specialized investment fund based in New York United States for 24 million the 2020 Atlas Contract. 